117 related articles for article (PubMed ID: 12939413)
21. Urinary F2-isoprostane metabolite analysis: a step closer to obtaining a reliable measure of oxidative stress?
Kelly FJ
Clin Exp Allergy; 2001 Mar; 31(3):355-6. PubMed ID: 11260144
[No Abstract] [Full Text] [Related]
22. Exhaled breath condensate isoprostanes are elevated in patients with acute lung injury or ARDS.
Carpenter CT; Price PV; Christman BW
Chest; 1998 Dec; 114(6):1653-9. PubMed ID: 9872202
[TBL] [Abstract][Full Text] [Related]
23. Oxidative stress and cardiovascular complications in diabetes: isoprostanes as new markers on an old paradigm.
Mezzetti A; Cipollone F; Cuccurullo F
Cardiovasc Res; 2000 Aug; 47(3):475-88. PubMed ID: 10963721
[TBL] [Abstract][Full Text] [Related]
24. Isoprostanes as oxidant stress markers in coronary reperfusion.
Meydani M
Nutr Rev; 1997 Nov; 55(11 Pt 1):404-7. PubMed ID: 9420453
[No Abstract] [Full Text] [Related]
25. F2-isoprostanes in Alzheimer and other neurodegenerative diseases.
Montine TJ; Montine KS; McMahan W; Markesbery WR; Quinn JF; Morrow JD
Antioxid Redox Signal; 2005; 7(1-2):269-75. PubMed ID: 15650414
[TBL] [Abstract][Full Text] [Related]
26. Plasma levels of 8-epiPGF2alpha, an in vivo marker of oxidative stress, are not affected by aging or Alzheimer's disease.
Feillet-Coudray C; Tourtauchaux R; Niculescu M; Rock E; Tauveron I; Alexandre-Gouabau MC; Rayssiguier Y; Jalenques I; Mazur A
Free Radic Biol Med; 1999 Aug; 27(3-4):463-9. PubMed ID: 10468223
[TBL] [Abstract][Full Text] [Related]
27. Lipid peroxidation in mice fed a choline-deficient diet as evaluated by total hydroxyoctadecadienoic acid.
Yoshida Y; Itoh N; Hayakawa M; Habuchi Y; Inoue R; Chen ZH; Cao J; Cynshi O; Niki E
Nutrition; 2006 Mar; 22(3):303-11. PubMed ID: 16500556
[TBL] [Abstract][Full Text] [Related]
28. Relationship of urinary isoprostanes to prostate cancer occurrence.
Brys M; Morel A; Forma E; Krzeslak A; Wilkosz J; Rozanski W; Olas B
Mol Cell Biochem; 2013 Jan; 372(1-2):149-53. PubMed ID: 22983829
[TBL] [Abstract][Full Text] [Related]
29. 8-Isoprostane as a biomarker of oxidative stress in interstitial lung diseases.
Montuschi P; Ciabattoni G; Paredi P; Pantelidis P; du Bois RM; Kharitonov SA; Barnes PJ
Am J Respir Crit Care Med; 1998 Nov; 158(5 Pt 1):1524-7. PubMed ID: 9817703
[TBL] [Abstract][Full Text] [Related]
30. Lipid peroxidation in aging brain and Alzheimer's disease.
Montine TJ; Neely MD; Quinn JF; Beal MF; Markesbery WR; Roberts LJ; Morrow JD
Free Radic Biol Med; 2002 Sep; 33(5):620-6. PubMed ID: 12208348
[TBL] [Abstract][Full Text] [Related]
31. Free radicals in Alzheimer's disease: Lipid peroxidation biomarkers.
Peña-Bautista C; Baquero M; Vento M; Cháfer-Pericás C
Clin Chim Acta; 2019 Apr; 491():85-90. PubMed ID: 30685358
[TBL] [Abstract][Full Text] [Related]
32. Novel indices of oxidant stress in cardiovascular disease: specific analysis of F2-isoprostanes.
Praticò D; Reilly M; Lawson JA; FitzGerald GA
Agents Actions Suppl; 1997; 48():25-41. PubMed ID: 9177098
[TBL] [Abstract][Full Text] [Related]
33. Plasma antioxidant status, immunoglobulin g oxidation and lipid peroxidation in demented patients: relevance to Alzheimer disease and vascular dementia.
Polidori MC; Mattioli P; Aldred S; Cecchetti R; Stahl W; Griffiths H; Senin U; Sies H; Mecocci P
Dement Geriatr Cogn Disord; 2004; 18(3-4):265-70. PubMed ID: 15286458
[TBL] [Abstract][Full Text] [Related]
34. F2-isoprostanes biomarkers of lipid peroxidation: their utility in evaluation of oxidative stress induced by toxic agents.
Piłacik B; Nofer TW; Wasowicz W
Int J Occup Med Environ Health; 2002; 15(1):19-27. PubMed ID: 12038860
[TBL] [Abstract][Full Text] [Related]
35. Measurement of 8-epi-PGF2alpha as a marker of lipid peroxidation in vivo by immunoaffinity extraction and gas chromatography-mass spectrometry.
Gopaul NK; Anggård EE
Methods Mol Biol; 2003; 225():329-42. PubMed ID: 12769500
[No Abstract] [Full Text] [Related]
36. Concentration of 8-isoprostanes in the exhaled breath condensate as a marker of oxidative stress in patients with type 1 diabetes.
Pękala-Wojciechowska A; Poznański M; Szyszow K; Antczak A
Adv Respir Med; 2018; 86(1):3-6. PubMed ID: 29490415
[TBL] [Abstract][Full Text] [Related]
37. The lipid peroxidation in breast cancer patients.
Kedzierska M; Olas B; Wachowicz B; Jeziorski A; Piekarski J
Gen Physiol Biophys; 2010 Jun; 29(2):208-10. PubMed ID: 20577033
[TBL] [Abstract][Full Text] [Related]
38. Lipids' peroxidation markers in Alzheimer's disease and vascular dementia.
Gustaw-Rothenberg K; Kowalczuk K; Stryjecka-Zimmer M
Geriatr Gerontol Int; 2010 Apr; 10(2):161-6. PubMed ID: 20446930
[TBL] [Abstract][Full Text] [Related]
39. Modulation of AD neuropathology and memory impairments by the isoprostane F2α is mediated by the thromboxane receptor.
Lauretti E; Di Meco A; Chu J; Praticò D
Neurobiol Aging; 2015 Feb; 36(2):812-20. PubMed ID: 25457549
[TBL] [Abstract][Full Text] [Related]
40. Measurement of F(2)-isoprostanes unveils profound oxidative stress in aged rats.
Roberts LJ; Reckelhoff JF
Biochem Biophys Res Commun; 2001 Sep; 287(1):254-6. PubMed ID: 11549283
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
